WO2017202962A1 - Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd) - Google Patents

Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd) Download PDF

Info

Publication number
WO2017202962A1
WO2017202962A1 PCT/EP2017/062625 EP2017062625W WO2017202962A1 WO 2017202962 A1 WO2017202962 A1 WO 2017202962A1 EP 2017062625 W EP2017062625 W EP 2017062625W WO 2017202962 A1 WO2017202962 A1 WO 2017202962A1
Authority
WO
WIPO (PCT)
Prior art keywords
pd
copd
patient
cells
tumor
Prior art date
Application number
PCT/EP2017/062625
Other languages
French (fr)
Inventor
Diane DAMOTTE
Ronald Herbst
Jérôme BITON
Claudie BANTSIMBA MALANDA
Original Assignee
INSERM (Institut National de la Santé et de la Recherche Médicale)
Medimmune, Llc
Université Paris Descartes
Université Pierre Et Marie Curie (Paris 6)
Université Paris Diderot - Paris 7
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP16305597 priority Critical
Priority to EP16305597.3 priority
Application filed by INSERM (Institut National de la Santé et de la Recherche Médicale), Medimmune, Llc, Université Paris Descartes, Université Pierre Et Marie Curie (Paris 6), Université Paris Diderot - Paris 7 filed Critical INSERM (Institut National de la Santé et de la Recherche Médicale)
Publication of WO2017202962A1 publication Critical patent/WO2017202962A1/en

Links